ARCHIVES

OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent

This article is from The Cancer Letter archive.

Vol. 09 No. 15 | April 15, 1983

Download PDF Visit The Full Archive

Related Articles

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996